232 related articles for article (PubMed ID: 1457191)
1. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins.
Kozlowski PA; Jackson S
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191
[TBL] [Abstract][Full Text] [Related]
2. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
3. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
[TBL] [Abstract][Full Text] [Related]
4. Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.
Belec L; Meillet D; Gaillard O; Prazuck T; Michel E; Ngondi Ekome J; Pillot J
Clin Exp Immunol; 1995 Jul; 101(1):100-6. PubMed ID: 7621578
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
6. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
[TBL] [Abstract][Full Text] [Related]
7. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
Kozlowski PA; Chen D; Eldridge JH; Jackson S
AIDS Res Hum Retroviruses; 1994 Jul; 10(7):813-22. PubMed ID: 7986587
[TBL] [Abstract][Full Text] [Related]
8. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection.
Janoff EN; Jackson S; Wahl SM; Thomas K; Peterman JH; Smith PD
J Infect Dis; 1994 Aug; 170(2):299-307. PubMed ID: 8035014
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of IgA anti-HIV antibodies in plasma from patients with HIV infection.
Matsuda S; Noda M; Toyota A; Tokumoto S; Miyata M
Microbiol Immunol; 1997; 41(10):785-90. PubMed ID: 9403502
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission.
Mann DL; Hamlin-Green G; Willoughby A; Landesman SH; Goedert JJ
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):617-22. PubMed ID: 7513762
[TBL] [Abstract][Full Text] [Related]
11. Serum IgA-mediated neutralization of HIV type 1.
Burnett PR; VanCott TC; Polonis VR; Redfield RR; Birx DL
J Immunol; 1994 May; 152(9):4642-8. PubMed ID: 8157978
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
[TBL] [Abstract][Full Text] [Related]
13. IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. Swiss Neonatal HIV Study Group.
Schüpbach J; Tomasik Z; Jendis J; Böni J; Seger R; Kind C
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):421-7. PubMed ID: 8158535
[TBL] [Abstract][Full Text] [Related]
14. An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease.
Hocini H; Iscaki S; Bouvet JP; Kazatchkine MD; Bélec L
J Immunol Methods; 2000 Feb; 235(1-2):53-60. PubMed ID: 10675757
[TBL] [Abstract][Full Text] [Related]
15. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
16. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
18. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.
Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C
Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823
[TBL] [Abstract][Full Text] [Related]
19. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
[TBL] [Abstract][Full Text] [Related]
20. Lack of IgA subclass restriction in antibody response to phosphorylcholine, beta lactoglobulin and tetanus toxoid.
Conley ME; Briles DE
Immunology; 1984 Nov; 53(3):419-26. PubMed ID: 6490093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
